These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21115578)

  • 61. [STAGING SYSTEMS OF HEPATOCELLULAR CARCINOMA].
    Tumanova UN; Shchegolev AI
    Eksp Klin Gastroenterol; 2016; (7):121-8. PubMed ID: 30284434
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
    Ballesta AM; Calvet X; Filella X; Bruix J; Bru C; Molina R; Rodes J
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):39-41. PubMed ID: 2480420
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic prediction in patients with hepatocellular carcinoma.
    Sala M; Forner A; Varela M; Bruix J
    Semin Liver Dis; 2005; 25(2):171-80. PubMed ID: 15918146
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The treatment of hepatocellular carcinoma: an update].
    Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
    Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 67. TNM/Okuda/Barcelona/UNOS/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: concepts, perspectives, and radiologic implications.
    Faria SC; Szklaruk J; Kaseb AO; Hassabo HM; Elsayes KM
    Abdom Imaging; 2014 Oct; 39(5):1070-87. PubMed ID: 24695938
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of hepatocellular carcinoma.
    Liccioni A; Reig M; Bruix J
    Dig Dis; 2014; 32(5):554-63. PubMed ID: 25034288
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Why no consensus prognostic classification for hepatocellular carcinoma?].
    Barbare JC; Bellenguez A; Diouf M
    Rev Prat; 2013 Feb; 63(2):218-9. PubMed ID: 23513789
    [No Abstract]   [Full Text] [Related]  

  • 70. The size of the problem: clinical algorithms.
    Forner A; Bruix J
    Dig Dis; 2013; 31(1):95-103. PubMed ID: 23797130
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons' perspective.
    Yang T; Lau WY; Zhang H; Huang B; Lu JH; Wu MC
    World J Gastroenterol; 2015 Jul; 21(27):8256-61. PubMed ID: 26217077
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New possibilities in hepatocellular carcinoma treatment.
    Rasool M; Rashid S; Arooj M; Ansari SA; Khan KM; Malik A; Naseer MI; Zahid S; Manan A; Asif M; Razzaq Z; Ashraf S; Qazi MH; Iqbal Z; Gan SH; Kamal MA; Sheikh IA
    Anticancer Res; 2014 Apr; 34(4):1563-71. PubMed ID: 24692683
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016.
    Yu SJ
    Clin Mol Hepatol; 2016 Mar; 22(1):7-17. PubMed ID: 27044761
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Shaping the future management of hepatocellular carcinoma.
    Abou-Alfa G; Colombo M
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S20-3. PubMed ID: 23457036
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of current staging systems on treatment strategy for HBV-related hepatocellular carcinoma.
    Yan X; Qiu Y
    Cancer Lett; 2016 Sep; 379(2):220-4. PubMed ID: 26282785
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Challenges of Clinical Research on Hepatocellular Carcinoma.
    Kudo M; Kitano M; Sakurai T; Nishida N
    Dig Dis; 2015 Oct; 33(6):780-90. PubMed ID: 26488399
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey.
    Toyoda H; Tada T; Johnson PJ; Izumi N; Kadoya M; Kaneko S; Kokudo N; Ku Y; Kubo S; Kumada T; Matsuyama Y; Nakashima O; Sakamoto M; Takayama T; Kudo M;
    J Gastroenterol; 2017 Oct; 52(10):1112-1121. PubMed ID: 28224228
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Classification and staging of hepatocellular carcinoma: an aid to clinical decision-making.
    Addissie BD; Roberts LR
    Clin Liver Dis; 2015 May; 19(2):277-94. PubMed ID: 25921663
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alpha-fetoprotein testing is still necessary for the detection of small hepatocellular carcinomas.
    Shim JJ; Kim H; Lee CK; Jang JY; Kim BH
    J Clin Gastroenterol; 2014 Apr; 48(4):384-5. PubMed ID: 24275710
    [No Abstract]   [Full Text] [Related]  

  • 80. Diagnosis, staging and treatment of hepatocellular carcinoma.
    França AV; Elias Junior J; Lima BL; Martinelli AL; Carrilho FJ
    Braz J Med Biol Res; 2004 Nov; 37(11):1689-705. PubMed ID: 15517086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.